FDA Approval of Product Registration. PRONOVA shall use commercially reasonable efforts to ensure that Abbott obtains an FDA approval for the Product for the indication HTG in the Territory as soon as reasonably practicable following the date of this Agreement. Prior to the date RELIANT receives the Registration, RELIANT shall have no obligation to contribute to or participate in the filing of any Registration in order to obtain the FDA approval for the Product.
Appears in 5 contracts
Samples: License and Supply Agreement, License & Supply Agreement (Reliant Pharmaceuticals, Inc.), License & Supply Agreement (Reliant Pharmaceuticals, Inc.)